11/3/2026

speaker
Operator
Conference Call Operator

Good day and thank you for standing by. Welcome to the N of H first quarter 2027 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Ryan Kubota, Director of Investor Relations. Please go ahead.

speaker
Ryan Kubota
Director of Investor Relations

Thank you, Operator. Good afternoon, and thank you all for joining the Innovate 2027 Fiscal First Quarter Earnings Call. With me today is Patrick Blair, CEO, and Ben Adams, CFO. Jen Brown, President and COO, will also be joining the Q&A portion of the call. Today, after the market closed, we issued an earnings press release containing detailed information on our fiscal first quarter results. You may access the release on the investor relations section of our company website, innovage.com. For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today. Tuesday, November 3, 2026, and have not been updated subsequent to this call. During our call, we will refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings press release posted on our website. We may also make statements that are considered forward-looking, including those related to our 2027 fiscal year projections and guidance, future growth prospects and growth strategy, our clinical and operational value initiatives, and other investments in technology and artificial intelligence, the impact of ongoing macroeconomic, geopolitical and industry-related challenges, reductions in page reimbursement rates and changes in risk adjustment methodologies, legal proceedings, enforcement actions and litigation and disputes and other expectations. Listeners are cautioned that our forward-looking statements involve certain assumptions that are inherently subject to risks and uncertainties that can cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our annual report on Form 10-K for fiscal year 2026 and any subsequent reports filed with the SEC. After the completion of our prepared remarks, we will open the call for questions. I will now turn the call over to our CEO, Patrick Blair. Patrick.

speaker
Patrick Blair
Chief Executive Officer

Thank you, Ryan, and good afternoon, everyone. I'd like to begin by thanking our In of Age colleagues, Our participants and their families, our government partners, and our shareholders for their continued support. Our results reflect the hard work of our teams across the organization and their commitment to delivering high quality coordinated care to some of our nation's most vulnerable seniors. We're pleased with our first quarter results and the strong start to fiscal 2027. For the quarter, we reported revenue of $264.8 million Center-level contribution margin of $63.6 million and adjusted EBITDA of $31.3 million. Compared with the first quarter of last year, revenue increased 12.1%, adjusted EBITDA grew more than 75%, and our ending census reached 8,420, an increase of 6.7%. What's particularly encouraging is that the census and profitability are both growing, and that's the combination we want. Our performance reflects the benefits of the investments we've made over the past several years, along with continued discipline in how we manage our operations and the cost of care. And importantly, we believe this quarter is another indication of the consistency and durability of the progress we've made. One quarter doesn't make a trend. and rate timing and utilization move results around. But the general direction has been the same for 13 quarters now. We're entering fiscal 2027 with good momentum, a strong foundation and confidence in our ability to execute against the priorities we've established for the year. With that backdrop, I'd like to spend a few minutes discussing how we plan to continue building on this foundation to support our long-term growth ambitions. Last quarter, we introduced the next chapter of the company's evolution, which we refer to as InnovAge 3.0. At its core, this is about building on the progress we've made over the last several years and continuing to develop the capabilities needed to support our long-term strategy. This chapter is focused on building the capabilities, leadership, and infrastructure needed to support our growth ambitions and to enable the company to operate successfully on a larger scale. We've made substantial investments in our clinical operations, technology, compliance infrastructure, and management systems. We believe the business is steadier for it and there's more to build on. These investments have established a strong foundation for the business and our focus now is on building upon that foundation to support the next stage of growth. Our priorities are focused on a few key areas. First, we're continuing to enhance our clinical and operational capabilities. including how we leverage EPIC data and analytics to support our care teams, improve productivity, and drive greater consistency and performance across our centers. Second, we're investing in the systems and processes that support census growth from expanding referral partnerships, improving the onboarding of new participants, and strengthening our end-to-end revenue accounting and eligibility operations. These capabilities become increasingly important as we serve more seniors through our existing centers and pursue additional growth opportunities. Third, we're early on AI. We're looking at where we can help clinicians make decisions and take administrative work off our teams. And we'll only pursue what we believe helps improve quality of care and decreases costs. An important part of this work is continuing to strengthen our center-led approach to care delivery. Our center leadership teams already run their centers well and are accountable for delivering high quality care, maintaining compliance, and achieving strong clinical and financial performance. As we grow, our focus is on better aligning our enterprise capabilities, including people, process, technology, and clinical expertise, to equip these leaders to deliver even stronger performance. Ultimately, this is about continuing to build on what's working well today While developing the capabilities needed for tomorrow. By better aligning our enterprise resources with the needs of our centers, we believe we can support strong performance, greater consistency, and the ability to serve more participants as we grow. As we look ahead, we are also increasingly focused on the opportunities to extend our growth beyond existing centers. Growing census within our footprint remains the priority. We believe there is meaningful opportunity to serve more participants through our existing infrastructure, and we continue to invest in the capabilities needed to support that growth. At the same time, the progress we've made in strengthening our business puts us in a position to spend more time on partnerships and acquisitions, adjacent opportunities that fit our model, and new pace centers. We believe the company has several advantages as we evaluate these opportunities, including our scale, Operating experience across multiple states, established clinical administrative infrastructure, and experience working with health systems and government partners. We'll be selective. Any opportunities must align with what we already do well, meet our quality and operating model standards, and earn an attractive return. Most of this is still being evaluated, and we don't want to get ahead of ourselves, but over time, we think it can become a bigger part of our growth. We believe these investments will not only help us deliver better care and stronger performance within our existing centers, but also position us to expand more efficiently and effectively into new markets and growth opportunities. I'd also like to address a topic that has come up frequently in our recent conversation with investors, the transition to the V-28 Medicare risk adjustment model and what it means for the company. The transition to V-28 has created meaningful reimbursement pressure for many Medicare Advantage plans, and investors understandably want to know whether PACE will experience similar challenges. We believe there are several important differences worth understanding. First, every PACE participant meets their state's nursing home level of care criteria. This is a different population than Medicare Advantage plans serve, which cover individuals across a broad range of health conditions and medical needs. Our participants have more chronic conditions, significantly greater medical complexity, and substantially more functional limitations compared to typical MA members. This distinction matters because V28 changes how certain diagnoses contribute to Medicare risk scores. Some conditions receive less weight or no longer contribute to the calculation, while others, including certain serious conditions, receive greater recognition. For example, Consider a relatively healthy Medicare Advantage member whose risk score is driven by just a few chronic conditions. If one of those conditions is removed or receives less weight under V28, the impact on the individual's risk score can be significant. Now consider a typical PACE participant living with multiple serious medical conditions, potentially including dementia, heart disease, and other complex diagnoses. While V28 may reduce the weight assigned to certain conditions, Others continue to be recognized, and some may receive greater weight. The impact ultimately depends on the participant-specific combination of diagnoses. Second, PACE has a distinct payment methodology, known as a frailty factor, that recognizes the functional frailty of the population you serve. Two individuals may have similar medical diagnoses, but one may live independently while the other requires assistance with bathing, dressing, mobility, and other daily activities. PACE's Medicare payment methodology includes a separate frailty adjustment designed to recognize these additional care needs beyond what diagnosis-based risk scores alone capture. The short version is V28 matters, but PACE isn't Medicare Advantage, and our fiscal 2027 guidance already reflects the expected impact of a V28 phase-in. We continue to expect a 1.5% to 2% increase in our Medicare rates effective January 1st. Reflecting our assessment of the various factors affecting reimbursement, including V28. So while V28 represents an important change in Medicare reimbursement, we believe its impact on the company needs to be evaluated in the context of the unique population we serve and the distinct PACE payment model. Before I close, I'd like to briefly highlight another important milestone for the company, the successful completion of our recent secondary offering. The transaction included the sale of 11.5 million shares by our affiliated shareholders, TCO Group Holdings, the investment vehicle controlled by Welsh Carson and Apex, including the full exercise of the underwriters over allotment option. No new shares were issued or sold by the company, and the company did not receive any proceeds from the offering. While we're pleased with the successful execution of the offering and the resulting increase in our public float in trading liquidity, We believe the offering signifies more than the shares involved in the transaction. Over the past several months, we've had the opportunity to engage with a broad range of institutional investors, many of whom were learning about InnovAge and the PACE model for the first time. What we found particularly encouraging was the level of interest in the PACE model itself, its ability to deliver comprehensive coordinated care to frail seniors, the value it creates for government payers, and the significant opportunity to expand access to this model of care. To us, the successful offering is a signal that investors are starting to see the progress we've made and what pace can be, and the opportunity for our company to extend its reach through both organic growth and additional growth channels over time. We appreciate the continued support of Welsh Carson and Apex, as well as the confidence of our new and existing investors. To close, it was a strong start to fiscal 2027. Our first quarter results reflect continued execution across the business and reinforce our confidence in the direction we're heading. We have a solid base, a more capable organization, and room to grow in our existing footprint while we pursue new markets selectively. And most importantly, we believe the opportunity ahead of us remains substantial. As the nation's aging population continues to grow, So it is the need for innovative, cost-effective models of care that allow frail seniors to remain in their homes and communities. We believe PACE is uniquely positioned to meet that need, and InnovAge is well positioned to play a leading role in expanding access to this important model of care. We're encouraged by our momentum, confident in our strategy, and remain focused on disciplined execution, all while creating sustainable long-term value for our participants, government partners, and shareholders. With that, I'll turn the call over to Ben to discuss our financial results in greater detail.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API